Generics 43

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Glycopyrrolate manufacturers

43 products found

Filters

43 products found

glycopyrrolate

Vials 0.1 mg/ml - 1 ml, 2 ml, 5 ml, 20 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Robinul®
Manufacturer #252
This company is a leading player in the pharmaceutical industry, boasting decades of experience in research, development, and manufacturing. They specialize in the production of a wide range of pharmaceutical ingredients (APIs) and finished dosage forms (FDFs) for both human and veterinary use. Their product portfolio spans multiple therapeutic areas, including but not limited to, oncology, cardiology, and other essential therapeutic categories. They offer a comprehensive range of services, including contract manufacturing (CMO) and the production of over-the-counter (OTC) products. The company holds EU and US GMP approvals for its production lines, ensuring adherence to rigorous quality standards. Their production lines encompass various dosage forms, including solids, liquids, and injectables. Their global presence extends across Europe and North America, with a network of 10 manufacturing facilities. They have a strong commitment to research and development, with dedicated teams focusing on innovative solutions and advancements in the pharmaceutical field.

Manufacturer usually replies in 12 days

glycopyrrolate

Vials, injection 0.2 mg / 1 ml, 0.4 mg / 1 ml, 1 mg / 5 ml, 4 mg / 20 ml

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #18871
This American pharmaceutical company specializes in manufacturing and supplying affordable generic medications across various therapeutic areas. With over a decade of experience, they offer a wide range of bioequivalent alternatives, including injectables, ophthalmics, oral solutions, and oral solids. Their commitment to innovation and quality is reflected in their state-of-the-art manufacturing facilities and robust intellectual property pipeline. The company prioritizes patient safety and efficacy, adhering to strict GMP certifications and holding product patents. They serve patients, caregivers, and healthcare professionals across the EU, North America, and other regions.

Manufacturer usually replies in 4 days

glycopyrrolate

Inhalation powder tbd

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Unavailable markets
United States
Manufacturer #13159
This company is a driving force in developing innovative treatments and technologies for a range of medical needs. Focusing on areas like psychiatry & neurology, oncology, urology, women's health, rare disease, and cell & gene therapy, they have a diverse pipeline of preclinical and clinical programs. Their technology-driven approach aims to bring patient-first solutions to market faster. While specific details about their production lines (prescription medications, over-the-counter drugs, medical devices, supplements) and GMP certifications are not provided, their commitment to research and development in key therapy areas suggests a broad scope of products. The company operates in regions like the EU and North America, emphasizing global impact.

Manufacturer usually replies in 3 days

Want to see all 43 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible